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4Sommario
L'epilessia  e fra le malattie neurologiche pi u frequenti: nel mondo colpisce circa
43 milioni di persone. Questo tesi tratta di un caso particolare di problema di
analisi multicriterio. Il problema studiato proviene dal dominio medico ad di
rilevanza pratica molto importante. Dato un paziente aetto da epilessia qual' e
il modo migliore di diagnosticare e curare la malattia? Questa domanda contiene
in s e lo scopo di questa tesi. Il modo pi u comune per arontare un problema
di ottimizzazione multi-obiettivo  e quello di applicare un'ottimizzazione pare-
tiana tra le soluzioni. Viene qui proposto un modello basato sulla valutazione
del rischio che utilizza strumenti sviluppati nel campo della analisi decisionale
multicriteria (MCDA).
Summary
Epilepsy is among the most common neurological diseases: in the world aects
about 43 million people. This thesis is a special case of multicriteria analysis
problem. Studied the problem comes from the medical domain is of practical
relevance to very important. Given a patient with epilepsy, what is the best way
to diagnose and treat the disease? This question contains within itself the goal
of this thesis. The most common way to deal with a problem of multi-objective
optimization is to apply an optimization between the Pareto solutions. Here is
proposed a model based on risk assessment using tools developed in the eld of
multicriteria decision analysis (MCDA).
5Chapter 1
Introduction
As with any new technology or science developing a framework for selecting ap-
propriate diagnosis and treatment and making medical decisions with uncertainly
and incomplete information is the current challenge for the eld of engineering.
This requires mutiple set of information because of both the subjective illness
and the often-limited database of relevant experimental studies. One of the tools
widely used in risk assessment applications in similar situation is the Multiat-
tribute utility theory in general Multiple-criteria decision-making.
Engineers are always making design decisions. Poor decisions could result
in the loss of money, resources, and time. Therefore, it is important that engi-
neers make logical and well reasoned decisions. However, the decision process
can prove to be quite complicated, especially when trade os need to be made,
such as between ecacy and potential risk for patient treatment. Given the com-
plexity of technology and systems, when there are dozens of attributes, there are
can be hundreds of alternatives to choose from, which can lead to a seemingly
innite number of possible combinations. So, how does one choose the best com-
bination? The purpose for using utility theory in decision making is to create a
mathematical model to aid the process. It gives the decision maker the ability
to quantify the desirability of certain alternatives. Utility theory is for design
scenarios where uncertainty and risk are considered. The end result of using this
7method is a function which represents the designer's preferences, given a certain
set of design attributes. We believe that MCDA could be applied widely to sup-
port medical decision, diagnosis and treatment of epilepsy. The advantages of
using MCDA techniques are numerous : MCDA provides a formal way for com-
bining information from disparate sources. These qualities make decisions made
through MCDA more thorough and defensible than decisions made through less
structured methods. For example, MCDA could be used to support evaluation of
some treatments and diagnosis. Our approach for making ecient decisions on
appropriate for medical applications will allow joint consideration of the medical
factors (patient criticity) and side eects with associated uncertainties relevant
to selection of alternatives.
A generalized MCDA process will follow two basic steps: (1) generating al-
ternatives about epilepsy diagnosis and treatment options, success criteria, and
value judgments; and (2) ranking the alternatives by applying value weights.
The rst part of the process generates and denes choices, performance levels,
and preferences. The latter section methodically prunes non-feasible alternatives
by rst applying screening mechanisms (e.g., signicant potential risks, excessive
cost) and then ranking in detail the remaining alternative by MCDA techniques.
Although it is reasonable to expect that the process may vary in specic
details among patients applications , emphasis should be given to designing an
management structure that uses learning as a means for incorporating chang-
ing decision priorities or new knowledge from epilepsy testing. The tools used
within group decision making and scientic research are essential elements of the
overall decision process. "Solving" can be interpreted in dierent ways. It could
correspond to choosing the "best" alternative from a set of available alterna-
tives (where "best" can be interpreted as "the most preferred alternative" of a
decision maker). In our case, nding the best diagnosis and best treatment for
epileptic patients. Another interpretation of "solving" could be choosing a small
set of good alternatives, or grouping alternatives into dierent preference sets.
8An extreme interpretation could be to nd all "ecient" or "nondominated" al-
ternatives (which we will dene shortly). The diculty of the problem originates
from the presence of more than one criterion. There is no longer a unique opti-
mal solution to an MCDM problem that can be obtained without incorporating
preference information. Mathematically the multicriteria optimization problem
can be regarded as solved when the Pareto optimal set has been determined.
The notion of Pareto eciency is also useful in engineering. Given a set of
choices and a way of valuing them, the Pareto frontier or Pareto set or Pareto
front is the set of choices that are Pareto ecient.
9Chapter 2
Epilepsy and Seizures
Epilepsy is a common chronic neurological disorder characterized by seizures.
Epilepsy is among the most frequent neurological diseases: in the world aecting
an estimated 43 million people. Thirty percent of epilepsy patients between the
ages of 5 and 25 develop seizures related to illness or accidents involving an
injury to the head. As many as 50 percent of epilepsies continue into adulthood.
Epilepsy may be triggered in adulthood by head injuries, infectious diseases,
slow-growing tumors, or from circulation problems. In approximately 70 percent
of patients, there is no identiable cause of seizures. Seizures are classied as
partial or generalized. Partial seizures occur in one side, or hemisphere, of the
brain. Generalized seizures involve abnormal activity on both sides of the brain.
It's important distinguish Epilepsy and Epileptic Seizures because the last
one is a phenonmena instead the Epilepsy is a cronic patology that conistist in
seiuzures. There are a dierent type of epilepsy with own denite symtomps.
A Seizure is a temporary loss of awareness of, and/or control over, certain
body functions. It happens as a result of abnormal excessive or synchronous
neuronal activity in the brain. A seizure may cause a sudden change in alertness,
behavior, muscular movements, or feeling in the body. Twenty percent of all
seizures occur in children from age 5 and under. Although scientists have not
determined the exact cause of all seizures, some seizures can be related to brain
11injuries, infections, birth defects, brain tumors, or circulation disorders such as
strokes. Some seizures may have a mild warning sign called an aura. Examples
of auras include a bad taste in the mouth, an unpleasant odor, spots in front of
the eyes, or a feeling of anxiety or fear. Some patients describe a feeling of being
cold or hot before a seizure.
TYPE LEVEL OF CON-
SCIOUNESS
CHARACTERISTIC
Partial
Simple partial No change in consciouness Change in movement or behavior
Complex partial Change in consciouness Hallucinations, loss of awareness,
deja vu, fear, confusion, wander-
ing, change in movements such as
lip smacking, picking at clothing
Generalized
Tonic clonic Loss of consciouness Two types of muscle movement
First, muscles in the arms, legs
and torso become sti. These
muscles then exhibit uncontrol-
lable jerking movements.
Absence petit mal Brief loss of consciouness
less than 15 seconds
Response to environment im-
paired; less than 15 seconds star-
ing o, non-responsive eye blink-
ing
Myoclonic No change in consciouness Uncontrollable jerking of the
muscles of the arms, legs or torso
Table1 : international classication of seizure -SHANDS- university of 
orida
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Multi-criteria decision analysis
Multiple-criteria decision-making or multiple-criteria decision analysis is a sub-
discipline of operations research that explicitly considers multiple criteria in
decision-making environments. Whether in our daily lives or in professional
settings, there are typically multiple con
icting criteria that need to be evalu-
ated in making decisions. Cost or price is usually one of the main criteria. Some
measure of quality is typically another criterion that is in con
ict with the cost.
In purchasing a car, cost, comfort, safety, and fuel economy may be some of
the main criteria we consider. It is unusual to have the cheapest car to be the
most comfortable and the safest. In portfolio management, we are interested in
getting high returns but at the same time reducing our risks. Again, the stocks
that have the potential of bringing high returns typically also carry high risks of
losing money. In service industry, customer satisfaction and the cost of providing
service are two con
icting criteria that would be useful to consider.
In our daily lives, we usually weigh multiple criteria implicitly and we may be
comfortable with the consequences of such decisions that are made based on only
intuition. On the other hand, when stakes are high, it is important to properly
structure the problem and explicitly evaluate multiple criteria. In making the
decision of whether to be build a nuclear power plant or not, and where to build
it, there are not only very complex issues involving multiple criteria, but there
13are also multiple parties who are deeply aected from the consequences.
Structuring complex problems well and considering multiple criteria explic-
itly leads to more informed and better decisions. There have been important
advances in this eld since the start of the modern multiple criteria decision
making discipline in the early 1960s.
3.1 Operation alternatives
Are usually thought of as given, in the sense that they are a priori and strictly
dened. However, alternatives may result from the systematic exploration of the
objectives pursued in the decision situation considered. Especially in problems
of strategic nature, the challenge is to detect interesting alternatives not obvious
or apparent at rst sight- on the basis of the main concerns expressed during
problem identication. In other occasions, where decision makers face a large
number of a priori dened alternatives, a rst crucial step is to identify a man-
ageable set of 'good' or 'interesting' or 'representative' alternatives. Screening
or sorting techniques can facilitate the search for preferred alternatives. Finally,
alternatives may be implicitly dened as combinations of discrete actions. In
such cases, decision makers seek to determine the most attractive combination
(portfolio) of the available actions.
 Acknowledging uncertainty is another crucial element of MCDA problems.
The main cause of uncertainty is limited knowledge about external param-
eters that may in
uence the performances of the considered actions. This
type of uncertainty can be handled by constructing scenarios for various
possible values of these uncertain parameters, as well as by the exploitation
of probabilities in the treatment of stochastic events. In addition, decision
makers have to handle internal uncertainty stemming from hesitations dur-
ing the problem structuring process (which alternatives, how important are
the criteria, etc.). The problems solution depends greatly upon the way
14both external and internal uncertainties are taken into account and the
techniques used to incorporate them into the analysis.
 Decision makers or other stakeholders involved in the decision situation are
those identifying the nature of the problem and driving the solution pro-
cedure towards the preferred direction. Although the two terms are some-
times used interchangeably, for our purposes, decision makers are those
assigned with the responsibility to take the nal decision, whereas stake-
holders is a much broader notion encompassing any single individual or
group of people with an interest or concern in the examined problem. The
decision makers are thus expected to take into account the stakeholders
point of view depending on their overall managerial behaviour, the type
of the problem considered and the ability of stakeholders to assist or to
hamper the solutions implementation. However, the involvement of stake-
holders in the MCDA procedure is useful in capturing several aspects of
the problem and getting a better insight to its potential consequences.
 Environment refers to all those parameters dening the decision context.
They may include scal, legislative or cultural aspects, which may broaden
or restrict the scope of the analysis and impose constraints in the decision
making procedure. Even if all other elements are the same, the problems
solution might dier if the decision is taken in another location or time
period.
3.2 Criteria
Criteria represent the decision maker or other stakeholders points of view along
which it seems adequate to establish comparisons. There are two main ap-
proaches to determining the set of criteria, re
ecting the two ways of building a
MCDA problem. A top-down approach is compatible with "valuefocused think-
ing" where criteria are built in a hierarchical structure, known as "value tree",
15leading from primary goals to main (fundamental) objectives, which in turn
are further broken down to specic criteria. The bottom-up approach supports
"alternative-focused thinking", where criteria are identied through a systematic
elicitation process, and may subsequently grouped in broader categories. In both
cases, a coherent set of criteria presents the following properties:
 Value relevance: Criteria are linked to fundamental goals of the stakehold-
ers enabling them to specify preferences.
 Understandability: The concept behind each criterion is clear and there is
a common view about the preferred direction of the alternatives perfor-
mances.
 Measurability: The performance of alternatives can be expressed on either
a quantitative or a qualitative measurement scale.
 Completeness: The set of criteria strives to cover all important aspects of
the problem considered while still being concise and operational.
3.3 Pareto Optima
Pareto eciency, or Pareto optimality, is a concept in economics with applica-
tions in engineering. The term is named after Vilfredo Pareto (1848?1923), an
Italian economist who used the concept in his studies of economic eciency and
income distribution.
No part of a Pareto optimal solution can be improved without making some
other part worse. Figure 1 shows four geometric examples of Pareto optimality.
In these gures, the circles represent objectives that are satised best when the
area of the circle is maximized. The constraints are that the circles may not
overlap and must t within the triangle.
We might further impose a global objective function in this case that is equal
to the sum of the circle areas. Only one of these gures is globally optimal
16whereas three of them are Pareto optimal. One gure is not Pareto optimal
because the area of one circle may be enlarged without violating the constraints.
This can occur in a distributed design project because one of the other circles
has been moved or modied by one of the team members.
Pareto optimality is a predicate. While one may be able to assign a quanti-
tative metric, such as the area of the circle, the answer as to whether the global
solution is Pareto optimal is \yes" or \no". It does not matter initially how much
a circle can be enlarged, only that it can be. How much is to be evaluated after
the possibility is noted. A corollary is that Pareto optimality does not address
local extrema with respect to any utility. Neither does Pareto optimality provide
a method for choosing among preferences or alternatives.
Figure 3.1:
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Diagnosis
4.1 Diagnosis Operation Alternatives
We considered six diagnosis management alternatives, that are dened indepen-
dently of the epilepsy type. These management alternatives are dened following
the current diagnosis methods uses , such as:
Diagnosis
D1 EEG test
D2 CT test
D3 PET test
D4 MEG test
D5 MRI test
D6 Neuropsycological test
Table 2 - Diagnosis Alternatives for Epilepsy
Each operational alternative is characterized by a factor that increase the
expected "probability of success" of the assets. Figures 10, 11 show the decision
trees in which for each business line the operational alternatives are represented.
For each operational alternative there is a binomial outcome for the assets: fail-
ure (F) and success (S). Failure corresponds to the probability of the assets to be
no more functioning, while success corresponds to the probability of the assets
to provide the desired function at the level guaranteed by each operational al-
ternative. The probability of success is given by 1  Pf qi, where qi is inversely
19proportional to the degree of functionality brought by each operational.
4.1.1 EEG test - D1
Apart from the patient history and the neurological exam, the EEG (electroen-
cephalograph) is the most in
uential tool in the diagnosis of seizures and epilepsy.
It provides a record of ongoing electrical activity in the brain.
An EEG machine is a recording device connected by wires to electrodes pasted
at key points on the patients head. The electrodes pick up signals produced by
electrical discharge of neurons in the related areas of the brain; the amplied
signal from each electrode causes pens writing on a moving belt of paper to
jumpsimilar to the action of a seismograph when an earthquake occurs.
The resulting EEG tracing, with its record of electrical discharge, provides a
record of activity in key areas of the brain during the period of the test. Excessive
discharge (of the type that, if large enough, might cause a seizure) may show up
as a sharp spike or series of spikes; some patterns (such as the 3-per-second spike
and wave of absence seizures) are unique to particular forms of epilepsy.
EEG recordings of patients while awake are made with the eyes open and
with the eyes closed. A 
ashing light is used to assess whether the patient is
photosensitivethat is, if he or she will have a seizure in response to the stimulus
of a 
ashing light.
Hyperventilation (rapid over breathing) is another common trigger for seizures
and is also a feature of an EEG assessment. Almost all patients with typical ab-
sence seizures who are not receiving antiepilepsy medication will have the charac-
teristic 3-per-second spike wave EEG pattern during hyperventilation. Patients
may be asked to go to sleep during the test because EEG abnormalities are more
likely to show up during sleep.
If standard recordings do not produce evidence of seizures, 24-hour EEGs, or
portable home EEG monitoring devices may be used. Nasopharyngeal and sphe-
noidal electrodes (long wires inserted through the nose or inserted into the jaw
20(a) (b)
Figure 4.1: eeg
muscle) may produce information unobtainable from regular recordings. Grid
or depth electrodes may be implanted in the brain in a surgical procedure when
patients are being evaluated for epilepsy surgery and it is vital to get precise
information on where the seizure site is located.
If the type and cause of the seizures are unclear, a type of evaluation known
as intensive monitoring may be undertaken. In this procedure, people are video-
taped during an EEG recording session. The combined image of EEG tracings
and visible behavior helps the physician diagnose the epilepsy and identify af-
fected areas of the brain. Intensive closed circuit TV and EEG monitoring of this
type also helps distinguish between true epileptic seizures caused by electrical
discharge and non-epileptic seizures caused by psychological factors.
Various ictal (seizure) and interictal (between seizure) EEG patterns corre-
spond to specic seizure types and types of epilepsy, although the correlation
varies. While the EEG is almost always abnormal during a seizure, it may be
normal between seizures. Thus, lack of interictal EEG abnormalities does not
exclude a diagnosis of epilepsy. However, at some time, most epilepsy patients
have abnormal EEG discharges. In contrast, some persons with EEGs that show
epilepsy-like activity never have seizures. Thus physicians interpret EEG results
within the context of other information they are gathering.
21Despite some limitations, however, the EEG remains the most important
clinical tool in evaluating patients with suspected seizures.
4.1.2 CT test - D2
Computed tomography (CT or CAT scan) was introduced in the United States
in the early 1970s. It revolutionized the practice of neurology and neurosurgery
by letting doctors see inside the brain without surgery for the rst time. The CT
scan is normal in most people with epilepsy. Abnormalities that might be seen are
atrophy (shrinking of the brain), scar tissue, strokes, tumors, or abnormal blood
vessels. Like ordinary x-rays, CT scans expose the patient to radiation. However,
the amount is low and the procedure is safe even if it needs to be repeated several
times. The scanner is a large machine, but less conning for patients than the
machine used for MRI. The advantages of CT scanning include speed and easy
availability in most places. It has lower resolution than MRI for showing brain
structures, however, and it is not as good at discriminating between the brain's
gray matter and white matter. Brain imaging is performed by special equipment.
Typically, if you have a CT or MRI scan, you will lie on an examination table
with your head resting on a curved support directly in front of the machine. The
table will then be moved gently towards the machine so the head is inside its
circular opening. A person having a CT scan may be given an injection of what's
called a contrast medium. This is a 
uid that goes up to the brain and makes
the scan easier to read. After the injection, some people may feel 
ushed, have
a metallic taste in the mouth, or feel a brief nausea.
In many ways CT scanning works very much like other x-ray examinations.
X-rays are a form of radiation like light or radio waves that can be directed at
the body. Dierent body parts absorb the x-rays in varying degrees.
In a conventional x-ray exam, a small amount of radiation is aimed at and
passes through the body, recording an image on photographic lm or a special
image recording plate. Bones appear white on the x-ray; soft tissue, such as
22(a)
Figure 4.2: ct scan
organs like the heart or liver, shows up in shades of gray and air appears black.
With CT scanning, numerous x-ray beams and a set of electronic x-ray de-
tectors rotate around you, measuring the amount of radiation being absorbed
throughout your body. At the same time, the examination table is moving
through the scanner, so that the x-ray beam follows a spiral path. A special
computer program processes this large volume of data to create two-dimensional
cross-sectional images of your body, which are then displayed on a monitor. This
technique is called helical or spiral CT.
4.1.3 PET test - D3
Another type of machine which produces images of the brain is the positron
emission tomography (PET) scanner. It produces color-coded pictures of brain
processes at work { including blood 
ow, use of glucose, and the presence of
oxygen.
PET (positron emission tomography) shows the brain's use of oxygen or sugar
(glucose). As with SPECT, a very low, safe dose of a radioactive substance is
injected into your arm and the scanner records its circulation. Not all types of
PET scans look alike, but often dierent colors are used to show areas of higher
or lower use of oxygen or sugar.
This test can help to identify the area of the brain from which partial seizures
23(a)
Figure 4.3: PET scan
arise. It may be performed in the period between seizures, the interictal period.
PET scans are expensive, and very few patients with epilepsy need them. Many
insurance companies will pay for PET scans for patients who are being evaluated
for epilepsy surgery.
4.1.4 MEG test - D4
Magnetoencephalography (MEG), also known as Magnetic Source Imaging (MSI),
is a non-invasive scanning technique which provides information about the struc-
ture and function of the brain. It is a safe and painless procedure that detects
small biomagnetic signals produced by the brain, recording magnetic elds over
the surface of the head. These signals provide information about the location of
active brain areas. This allows us to see how dierent areas of the brain interact
with one another.
MEG can help to identify the areas of the brain that are emitting abnormal
electric currents that are causing the seizures. Often patients perform cognitive
tasks during the MEG, which helps to localize the learning and memory areas of
the brain. The MEG produces a high resolution image of the brain that relates
the functioning of the brain with behaviour.
One advantage that MEG has over PET and fMRI, which depend on changes
in blood 
ow in the brain, is that it is fast enough to provide information about
the millisecond by millisecond changes in neuronal ring, which PET and fMRI
24(a) (b)
Figure 4.4: meg test
cannot. MEG records magnetic signals that are produced by the responding
neurons, enabling us to see rapid brain potentials.
To some degree, MEG is similar to EEG (electroencephalography). An im-
portant dierence is that the skull and the tissue surrounding the brain aect
the magnetic elds measured by MEG much less than they aect the electri-
cal impulses measured by EEG. The advantage of MEG over EEG is therefore
greater accuracy owing to the minimal distortion of the signal. This allows for
more usable and reliable localization of brain function. When MEG is added
to magnetic resonance imaging (MRI), which shows brain structure, the combi-
nation of the images is extremely helpful for identifying areas of the brain that
may be generating a potential for seizures, as well as for localizing the electrical
activity in normal brain function.
In the evaluation of epilepsy, MEG is used to localize the source of epilep-
tiform brain activity, which most likely is the source of seizures. It is usually
performed with simultaneous EEG.
MEG may be helpful in the following situations:
It can improve the detection of potential sources of seizures by revealing the
exact location of the abnormalities, which may then allow physicians to nd
the cause of the seizures. It can help when MRI scans show a lesion but the
EEG ndings are not entirely consistent with the MRI information. An MEG
25(a) (b)
Figure 4.5: mri test
may be able to conrm that the epileptiform discharges (the brain waves typical
of epilepsy) are indeed arising from the lesion. Then a decision can be made
regarding surgery. In patients who have brain tumors or other lesions, the MEG
may be able to map the exact location of the normally functioning areas near
the lesion so that surgery can be planned to minimize postoperative weakness or
loss of brain function. In patients who have had past brain surgery, the electrical
eld measured by EEG may be distorted by the changes in the scalp and brain
anatomy. If further surgery is needed, MEG may be able to provide necessary
information without invasive EEG studies.
4.1.5 MRI and fMRI - D5
Magnetic Resonance Imaging (MRI) is a safe and non-invasive scanning tech-
nique. Instead of using x rays, the MRI is based on nuclear magnetic resonance.
In short, this means that all atoms have a nuclei that have their own resonant
frequency. If you disturb them they sing like tuning forks. The dierent struc-
tural components of the brain have atoms with nuclei that have their own unique
song. The MRI scan sends a high frequency alternating magnetic eld through
the brain, via electromagnets that surround the brain, thereby disturbing the
26various nuclei. The magnetic sensors in the scanner pick up the activity of the
nuclei.
A computer then generates a two or three dimensional image of the brain.
This detailed picture of brain structures (not function) helps physicians locate
possible causes of seizures and identify areas that may generate seizures. No
x-rays or radioactive material are used, therefore this procedure is not known to
be harmful.
An MRI oers doctors the best chance of nding the source of seizures. Be-
cause epilepsy can arise from scar tissue in the brain, an MRI can show scar tissue
and allow doctors to determine the nature of it. The images produced from the
MRI are extremely precise. The information provided by MRI is valuable in the
diagnosis and treatment of individuals with epilepsy and to determine whether
surgery would be benecial.
Additional Types of MRIs
A Functional MRI (fMRI) is a non-invasive technique that provides both an
anatomical and functional view of the brain. Similar to the MRI, fMRI uses
magnetic elds instead of x-rays to produce detailed pictures of the brain. This
technique allows us to localize specic areas of brain function by imaging patients
while they perform specic tasks. Therefore, functional MRI can identify regions
of the brain that are active during cognitive, sensory, and other tasks by detecting
changes in blood 
ow to particular areas of the brain. This information is often
very useful to the neurosurgeon; it helps physicians identify the exact location
of the source of the seizures.
The advantage of using an fMRI is that it can measure blood 
ow with-
out using radioactive tracers. Instead, fMRI takes advantage of the fact that
haemoglobin, an oxygen carrying molecule in the blood, contains an iron molecule
which has magnetic properties. When a magnetic eld is presented to the
brain, the haemoglobin molecules line up, like tiny magnets. fMRI indicates
the presence of brain activity because the haemoglobin molecules in areas of
27high brain activity lose some of the oxygen they are transporting. This makes
the haemoglobin more magnetic, thereby responding more strongly to the mag-
netic eld. The fMRI machine determines the relative activity of various areas
of the brain by detecting changes in the magnetic response of haemoglobin.
Advantages of fMRI: It can look at discrete areas of brain activation The nal
image depicts more detail than CT scans It can measure fast-changing physiology
better then the PET scan.
4.1.6 Neuropsycological tests - D6
Neuropsychological testing (also known as neuropsychometric testing) are de-
signed to assess a variety of brain functions, including memory, reading, compre-
hension, judgment, motor abilities, spatial perception and ability to process and
interpret information. The tests quantitatively measure these functions, thereby
demonstrating possible abnormalities of the brain.
Individuals with epilepsy occasionally report diculties with memory, con-
centration, or other cognitive areas. Neuropsychological tests assess these abil-
ities and provide information about a person's strengths and weaknesses. This
oers doctors some insight into the cause and severity of seizures. These tests
may help to identify the type of epilepsy an individual has, and locate the ori-
gin within the brain of the patient's seizures by determining which parts of the
brain are functioning abnormally. They may be used in evaluation for surgical
treatment.
Examples of commonly used tests: Wechsler Intelligence Scale for Children
(WISC) Bender Visual-Motor Gestalt Test: The visual test involves copying a
bunch of abstract designs. This test is good at identifying organic brain dam-
age. The motor test may involve sorting cards into dierent categories that
the patient needs to determine, based on the feedback of the clinician. Wech-
sler Adult Intelligence Scale (WAIS): used to help test memory, and retention
Minnesota Multiphasic Personality Inventory Rorschach Ink Blot Test Thematic
28Apperception Test (TAT) Sentence completion Goodenough draw-a-person test
Stanford-Binet intelligence Scale
4.2 Diagnosis Criteria
In order to mark out the eects and results of these diagnosis four evalutation
criteria were considered (Table3)
Criterion
C1 ecacy
C2 potential riscks
C3 execution time
C4 results time
Table 3 - Criteria considered for Diagnosis evalutation
Indicative values have been used for test purpose.
C1 C2 C3 C4
D1 9 1 3 3
D2 8 4 2 2
D3 6 4 1 8
D4 8 5 2 3
D5 8 1 3 7
D6 7 1 8 2
Table 4 - Criteria values considered as Diagnosis matrix input
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Treatment
5.1 Operation Alternatives
The problem is to rank treatments illustrated in Table 1 subject to multicriteria.
For the treatment of Epilepsy many methods can be applied. The evalutation
of the treatment methods from multiple points of view is dicult and has a
high degree of subjectivity. The complex and the original study with many
patients, over the usual number from related studies, can contribute greatly to
the evolution of this domain. We made a clinical study of the following treatment
methods of epilepsy.
Treatment
T1 Ketogenic Diet
T2 Lesionectomy
T3 Corpus Callosotomy
T4 Functional Hemispherectomy
T5 Multiple Subpial Transection
T6 Vagus Nerve Stimulation
T7 Drug therapy
Table 5 - Treatments Alternatives for Epilepsy
315.1.1 Ketogenic Diet - T1
The ketogenic diet is one of the oldest treatments for epilepsy. It is intended to
maintain the starvation or fastingmetabolism over a long period of time. When
the body is in a fasting state, it creates ketones, a by-product of fat-burning
metabolism. It has long been recognized that seizures often lessen or disappear
during periods of fasting in some individuals with epilepsy.
The diet is very high in fat and low in carbohydrates. When fat is the primary
source of calories, ketones are formed. The diet must be followed very strictly
and requires a signicant commitment to work eectively. Children on the diet
often will not gain weight or grow much during the time the diet is in use. After
that, however, growth is expected and should be carefully monitored.
The diet has been used mostly in children with dicult-to-control, generalized
epilepsies { such as those with the Lennox-Gastaut syndrome. Lennox-Gastaut
is a generalized epilepsy which is characterized by drop attacks or tonic-clonic
attacks (with violent, rhythmic convulsions) and often occurs in children with
other neurological conditions such as paralysis and mental retardation. It's often
very resistant to treatment. In this group of individuals, the diet can be as
successful as medications. Thus, it is most often recommended for children ages
2 through 10 or 12 years old who have been diagnosed with a generalized type
of epilepsy, and who have failed to respond to a variety of drugs. Recent studies
have shown that the diet may also be eective in those with partial seizures.
The diet is typically started with a period of fasting lasting until the body
produces a moderate to large amount of ketones. This initiation period usually
takes place in the hospital, so that the individual can be monitored for poten-
tial side eects such as vomiting, low blood sugar, dehydration, and seizures.
Medications may also be adjusted during this period to prevent sedation (the
tranquilizing eect of medications), another common side eect.
A two-month trial period is suggested for deciding whether the diet is eec-
tive. If eective, it is typically continued for two years. During this time, indi-
32viduals are often able to lessen the amount of medication they take for seizures.
Many children seem happier and more alert on the diet, even before medication
is signicantly lessened.
People on a ketogenic diet should be monitored by a dietician, nurse and
doctor { particularly a neurologist { familiar with its use. Specialized epilepsy
clinics are available to monitor a person on this diet.
Side eects of the ketogenic diet The ketogenic diet can have a variety of side
eects, including:
Dehydration this needs to be monitored very carefully as a certain degree of
dehydration is necessary to make the diet eective, but excessive dehydration can
have serious consequences. Constipation this is due to the lack of dietary bre
in the diet caused by omitting fruit, vegetables, grains and cereals. The epilepsy
specialist will have to prescribe a suitable, gentle laxative. Kidney or gallstones
may develop because of the high fat content of the diet. Children need to be
monitored regularly to check if they're developing kidney or gallstones. Vitamin
deciencies induced by omitting fruits, vegetables and grains. As mentioned
before, the child needs to take a vitamin and mineral supplement. Increased
blood cholesterol levels, particularly in children with an inborn defect in terms
of cholesterol metabolism. This can have serious consequences and the medical
team will monitor your child throughout her use of the diet. Refusal by the
child to follow such a diet. The ketogenic diet is unpalatable and may make
children feel marginalised because they cannot eat 'normal' foods. Behavioural
counselling may be necessary to help the child manage her diet.
Diculty in applying the diet. Foods for each meal have to be carefully
weighed and the volume of liquid the child drinks each day must be carefully
controlled. Some parents may nd it impossible to adhere to such a strict reg-
imen, particularly if they work or are away from home often. Short duration.
The ketogenic diet can generally not be applied for longer than two years.
335.1.2 Lesionectomy - T2
A lesionectomy is an operation to remove a lesion { a damaged or abnormally
functioning area { in the brain. Brain lesions include tumors, scars from a head
injury or infection, abnormal blood vessels, and hematomas (a swollen area lled
with blood).
A lesion causes seizures { also called the seizure focus { in about 20 per
centoo to 30 per centoo of people with epilepsy that do not improve after taking
medication (intractable or refractory epilepsy). It is not known for certain if the
lesion itself triggers the seizures, or if the seizures result from irritation to the
brain tissue surrounding the lesion. For this reason, surgery may also include
the removal of a small rim of brain tissue around the lesion, called lesionectomy
plus corticectomy.
Lesionectomy may be an option for people whose epilepsy is linked to a
dened lesion and whose seizures are not controlled by medication. In addition,
it must be possible to remove the lesion and surrounding brain tissue without
causing damage to areas of the brain responsible for vital functions, such as
movement, sensation, language, and memory. There also must be a reasonable
chance that the person will benet from surgery.
Candidates for lesionectomy undergo an extensive pre-surgery evaluation-
including seizure monitoring, electroencephalography (EEG) and magnetic res-
onance imaging (MRI). These tests help to pinpoint the location of the lesion
and conrm that the lesion is the source of the seizures. Another test to assess
electrical activity in the brain is EEG-video monitoring, in which video cameras
are used to record seizures while the EEG monitors the brain's activity. In some
cases, invasive monitoring { in which electrodes are placed inside the skull over a
specic area of the brain { is also used to further identify the tissue responsible
for seizures.
A lesionectomy requires exposing an area of the brain using a procedure called
a craniotomy. ("Crani" refers to the skull and "otomy" means "to cut into.")
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Figure 5.1: lesionectomy
After the patient is put to sleep with general anesthesia, the surgeon makes an
incision (cut) in the scalp, removes a piece of bone and pulls back a section of
the dura, the tough membrane that covers the brain. This creates a "window"
in which the surgeon inserts special instruments for removing the brain tissue.
Surgical microscopes are used to give the surgeon a magnied view of the lesion
and surrounding brain tissue. The surgeon utilizes information gathered during
pre-surgical brain imaging to help identify abnormal brain tissue and avoid areas
of the brain responsible for vital functions.
In some cases, a portion of the surgery is performed while the patient is
awake, using medication to keep the person relaxed and pain-free. This is done
so that the patient can help the surgeon nd and avoid vital areas of the brain.
While the patient is awake, the doctor uses special probes to stimulate dierent
areas of the brain. At the same time, the patient is asked to count, identify
pictures, or perform other tasks. The surgeon can then identify the area of the
brain associated with each task. After the brain tissue is removed, the dura and
bone are xed back into place, and the scalp is closed using stitches or staples.
Lesionectomy results are excellent in patients whose seizures are clearly as-
sociated with a dened lesion. Seizures usually stop once the lesion is removed.
5.1.3 Corpus Callosotomy - T3
The corpus callosum is a band of nerve bers located deep in the brain that con-
nects the two halves (hemispheres) of the brain. It helps the hemispheres share
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Figure 5.2: corpus callosotomy
information, but it also contributes to the spread of seizure impulses from one
side of the brain to the other. A corpus callosotomy is an operation that severs
(cuts) the corpus callosum, interrupting the spread of seizures from hemisphere
to hemisphere. Seizures generally do not completely stop after this procedure
(they continue on the side of the brain in which they originate). However, the
seizures usually become less severe, as they cannot spread to the opposite side
of the brain.
A corpus callosotomy, sometimes called split-brain surgery, may be performed
in patients with the most extreme and uncontrollable forms of epilepsy, when
frequent seizures aect both sides of the brain. A serious type of seizure { called
a drop attack { often results in the person having sudden falls with a high risk of
injury. In addition, people considered for corpus callosotomy do not experience
improvement after receiving treatment with anti-seizure medications.
A corpus callosotomy requires exposing the brain using a procedure called a
craniotomy. After the patient is put to sleep with anesthesia, the surgeon makes
an incision (cut) in the scalp, removes a piece of bone and pulls back a section of
36the dura, the tough membrane that covers the brain. This creates a "window"
in which the surgeon inserts special instruments for disconnecting the corpus
callosum. The surgeon gently separates the hemispheres to access the corpus
callosum. Surgical microscopes are used to give the surgeon a magnied view of
the brain structures.
In some cases, a corpus callosotomy is done in two stages. In the rst opera-
tion, the front two-thirds of the structure is cut, but the back section is preserved.
This allows the hemispheres to continue sharing visual information. If this does
not control the serious seizures, the remainder of the corpus callosum can be cut
in a second operation. After the corpus callosum is cut, the dura and bone are
xed back into place, and the scalp is closed using stitches or staples. The person
will continue taking anti-seizure drugs.
Corpus callosotomy is successful in stopping drop attacks in about 50 % to
75 % of cases. This can decrease the risk of injury and improve the person's
quality of life.
5.1.4 Functional Hemispherectomy - T4
The largest part of the brain, the cerebrum, can be divided down the middle
lengthwise into two halves, called hemispheres. A deep groove splits the left
and right hemispheres, which communicate through a thick band of nerve bers
called the corpus callosum. Each hemisphere is further divided into four paired
sections, called lobes { the frontal, parietal, occipital, and temporal lobes.
The two dierent sides or hemispheres are responsible for dierent types of
thinking. Most individuals have a distinct preference for one of these styles of
thinking and tend to have one side of the brain function much more than others.
For example, left hemisphere thinkers are logical, analytical, objective, while
right hemisphere thinkers are intuitive, creative, subjective, holistic thinkers.
A functional hemispherectomy is a procedure in which portions of one hemi-
sphere { which is used the least { are removed, and the corpus callosum is cut.
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Figure 5.3: functional hemispherectomy
This disconnects communication between the two hemispheres, preventing the
spread of seizures to the functional side of the brain.
This procedure generally is used only for people with epilepsy who do not
experience improvement in their condition after taking medication and who have
severe, uncontrollable seizures beginning in a non-functioning hemisphere. This
type of epilepsy often occurs in young children who have an underlying disease,
such as Rasmussen's encephalitis or Sturge-Weber syndrome, which has damaged
the hemisphere.
Candidates for functional hemispherectomy undergo an extensive pre-surgery
evaluation { including seizure monitoring, electroencephalography (EEG), and
magnetic resonance imaging (MRI). These tests help the doctor identify the dam-
aged hemisphere and conrm it as the source of the seizures. An intracarotid
amobarbital test, also called a WADA test, is done to determine which hemi-
sphere is dominant for critical functions such as speech and memory. During
this test, each hemisphere is alternately injected with a medication to put it to
sleep. While one side is asleep, the awake side is tested for memory, speech, and
ability to understanding speech.
A functional hemispherectomy requires exposing the brain using a procedure
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into." After the patient is put to sleep (general anesthesia), the surgeon makes
an incision (cut) in the scalp, removes a piece of bone and pulls back a section of
the dura, the tough membrane that covers the brain. This creates a "window"
in which the surgeon inserts special instruments for removing brain tissue. Sur-
gical microscopes are utilized to give the surgeon a magnied view of the brain
structures. During the procedure, the surgeon removes portions of the aected
hemisphere, often taking all of the temporal lobe but leaving the frontal and
parietal lobes. The surgeon also gently separates the hemispheres to access and
cut the corpus callosum. After the tissue is removed, the dura and bone are xed
back into place, and the scalp is closed using stitches or staples.
Most patients will need to continue taking anti-seizure medication, although
some may eventually be able to stop taking medication or have their dosages
reduced.
About 85 % of people who have a functional hemispherectomy will experience
signicant improvement in their seizures, and about 60 % will become seizure-
free. In many cases, especially in children, the remaining side of the brain takes
over the tasks that were controlled by the section that was removed. This often
improves a child's functioning and quality of life, as well as reduces or eliminates
the seizures.
5.1.5 Multiple Subpial Transection - T5
Sometimes brain seizures begin in a vital area of the brain { for example, in areas
that control movement, feeling, language, or memory. When this is the case, a
relatively new epilepsy treatment called multiple subpial transection (MST) may
be an option. MST stops the seizure impulses by cutting nerve bers in the outer
layers of the brain (gray matter), sparing the vital functions concentrated in the
deeper layers of brain tissue (white matter).
Most people with epilepsy can control their seizures with medication. How-
39ever, about 20 % of people with epilepsy do not improve with drugs. In some
cases, surgery to remove the part of the brain causing the seizures may be rec-
ommended.
MST may be an option for people who do not respond to medication and
whose seizures begin in areas of the brain that cannot be safely removed. In
addition, there must be a reasonable chance that the person will benet from
surgery. MST may be done alone or with the removal of a section of brain tissue
(resection). MST also may be used as a treatment for children with Landau-
Klener syndrome (LKS), a rare childhood brain disorder which causes seizures
and aects the parts of the brain that control speech and comprehension.
Candidates for MST undergo an extensive pre-surgery evaluation { including
seizure monitoring, electroencephalography (EEG), magnetic resonance imaging
(MRI), and positron emission tomography (PET). These tests help to pinpoint
the area in the brain where the seizures occur and determine if surgery is feasible.
Another test to assess electrical activity in the brain is EEG-video monitoring,
in which video cameras are used to record seizures as they occur, while the EEG
monitors the brain's activity. In some cases, invasive monitoring { in which
electrodes are placed inside the skull over a specic area of the brain { is also
used to further identify the tissue responsible for seizures. What Happens During
Multiple Subpial Transection?
MST requires exposing an area of the brain using a procedure called a cran-
iotomy. ("Crani" refers to the skull and "otomy" means "to cut into.") After
the patient is put to sleep with anesthesia, the surgeon makes an incision (cut)
in the scalp, removes a piece of bone and pulls back a section of the dura, the
tough membrane that covers the brain. This creates a "window" in which the
surgeon inserts his or her surgical instruments. The surgeon utilizes information
gathered during pre-surgical brain imaging to help identify the area of abnormal
brain tissue and avoid areas of the brain responsible for vital functions.
Using a surgical microscope to produce a magnied view of the brain, the
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just below the pia mater (subpial), the delicate membrane that surrounds the
brain (it lies beneath the dura). The cuts are made over the entire area identied
as the source of the seizures. After the transactions are made, the dura and bone
are xed back into place, and the scalp is closed using stitches or staples.
After MST, the patient generally stays in an intensive care unit for 24 to 48
hours and in a regular hospital room for three to four days. Most people who
have MST will be able to return to their normal activities, including work or
school, in six to eight weeks after surgery. Most patients will continue to take
anti-seizure medication. Once seizure control is established, medications may be
reduced or eliminated.
MST results in satisfactory improvement in seizure control in about 70% of
patients, although the procedure is still relatively new, and no long-term outcome
data are available. Children with LKS or other forms of epilepsy not controlled
by medication may have improved intellectual and psychosocial functioning fol-
lowing MST.
5.1.6 Vagus Nerve Stimulation (VNS) - T6
Vagus nerve stimulation (VNS) is a technique used to treat epilepsy. It involves
implanting a pacemaker-like device that generates pulses of electricity to stimu-
late the vagus nerve. The vagus nerve is one of the 12 cranial nerves, the paired
nerves that attach to the undersurface of the brain and relay information to and
from the brain. Cranial nerve bers conduct impulses between the brain and
other parts of the brain and various body structures, mostly in the head and
neck. The vagus nerve - the longest of the cranial nerves - also extends to or-
gans in the chest and abdomen. (The word vagus comes from a Latin word for
"wandering.')
Some cranial nerves bring information from the senses (like touch or sight)
to the brain (sensory) and some control muscles (motor). Other cranial nerves,
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Figure 5.4: vsn
like the vagus, have both motor and sensory functions. The vagus nerve serves
many organs and structures, including the larynx (voice box), lungs, heart and
gastrointestinal tract.
While the patient is asleep (general anesthesia), the stimulator device - which
is about the size of a silver dollar - is surgically placed under the skin in the upper
part of the chest. A connecting wire is run under the skin from the stimulator
to an electrode that is attached to the vagus nerve, which is accessible through
a small incision (cut) in the neck.
After it is implanted, the stimulator is programmed using a computer to
generate pulses of electricity at regular intervals, depending on the patient's
tolerance. For example, the device may be programmed to stimulate the nerve
for 30 seconds every ve minutes. The settings on the device are adjustable, and
the electrical current is gradually increased as the patient's tolerance increases.
Re-programming the stimulator can be done in the doctor's oce. The patient
also is given a hand-held magnet, which when brought near the stimulator, can
generate an immediate current of electricity to stop a seizure in progress or reduce
the severity of the seizure.
VNS is an add-on therapy, which means it is used in addition to another
42type of treatment. Patients who undergo VNS continue to take their seizure
medications. In some cases, however, it may be possible to reduce the dosage of
medication.
Brain cells communicate by sending electrical signals in an orderly pattern.
In people with epilepsy, this pattern is sometimes disrupted due either to an
injury or the person's genetic make-up, causing brain cells to emit signals in an
uncontrolled fashion. This creates over-excitement, somewhat like an electrical
overload in the brain, leading to seizures. Seizures can be produced by electrical
impulses from throughout the brain, called generalized seizures, or from a small
area of the brain, called partial seizures.
Most people with epilepsy can control their seizures with medications called
anti-convulsant or anti-seizure drugs. About 20 % of people with epilepsy do not
respond to anti-seizure medications. In some cases, surgery to remove the part
of the brain causing the seizures may be used. VNS may be a treatment option
for people whose seizures are not controlled by anti-seizure medications and who
are not considered good candidates for surgery; for example, if their seizures are
produced throughout the brain (generalized).
It is not known exactly how VNS works. It is known, however, that the vagus
nerve is an important pathway to the brain. It is thought that by stimulating
the vagus nerve, electrical energy is discharged upward into a wide area of the
brain, disrupting the abnormal brain activity responsible for seizures. Another
theory suggests that stimulating the vagus nerve causes the release of special
brain chemicals that decrease seizure activity.
The risks of VNS include injury to the vagus nerve or nearby blood vessels,
including the carotid artery and jugular vein. In addition, there are risks asso-
ciated with any surgical procedure, such as infection, bleeding and an allergic
reaction to the anesthesia.
VNS is not a cure, and the total elimination of seizures is rare. However, many
people who undergo VNS experience a signicant (more than 50 %) reduction
43in the frequency of seizures, as well as a decrease in seizure severity. This can
greatly improve the quality of life for people with epilepsy.
5.1.7 Drug Theraphy
The majority of epileptic seizures are controlled through drug therapy, partic-
ularly anticonvulsant drugs. The type of treatment prescribed will depend on
several factors including the frequency and severity of the seizures as well as the
person's age, overall health, and medical history. An accurate diagnosis of the
type of epilepsy is also critical to choosing the best treatment.
In general, for a given type of epilepsy there are only minor dierences among
appropriate drugs. The choice is most often based on other factors specic to
each patient, such as which side eects can be tolerated by the patient, other
illnesses they may have, and which delivery method is acceptable.
Although the dierent types of epilepsy vary greatly, in general, medications
can control seizures in about 70% of patients.
As is true of all drugs, the drugs used to treat epilepsy have side eects. The
occurrence of side eects depends on the dose, type of medication, and length of
treatment. The side eects are usually more common with higher doses but tend
to be less severe with time as the body adjusts to the medication. Anti-epileptic
drugs are usually started at lower doses and increased gradually to make this
adjustment easier.
5.2 Treatment Criteria
In order to mark out the eects and results of these treatments seven evalutation
criteria were considered (Table 6)
44Criterion
C1 ecacy
C2 invasiviness
C3 potential risks
C4 side eects
C5 hospitalization period
C6 costs
C7 remission period
C8 decrease in medication
C9 decrease in the number of
seizures
Table 6 - Criteria considered for treatments evalutation
Indicative values have been used for test purpose.
C1 C2 C3 C4 C5 C6 C7 C8 C9
T1 7 2 2 4 2 2 ? 5 6
T2 6 8 8 7 6 10 8 5 5
T3 5 7 8 7 6 10 7 5 6
T4 7 9 9 9 6 10 8 5 5
T5 6 6 7 7 6 10 8 5 5
T6 6 5 6 5 4 6 5 5 4
T7 5 3 3 6 3 5 ? 10 6
Table 7 - Criteria values considered as Treatments matrix input
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Proposed approach for
Risk-based MCDA for Epilepsy
Death Risk Reduction
6.1 Methods
A set of business line is dened as B = fbigK
i=1, where K is the number of
business lines. In this case study we considered only treatments and diagnosis
of the epilepsy, however an innite number of business lines may be dened and
considered at the same time.
A set of resource types is dened as RT = frtigH
i=1 where H is the number
of resource types. In this case study we considered only cost and ecacy of
treatments and diagnosis.
The budget can be written as B = fbigH
i=1, where ri is the quantity of resource
type rti .
A set of assets of business line is dened as Ai = fai;jgi=1;K;j=1;Ni , where Ni
is the number of assets of business line i.
A set of operational alternatives for each asset j of business line i is dened
as Oi;j;k = fOi;j;kgi=1;K;j=1;Ni;k=1;Mi;j where Mi;j is the number of operational
47alternatives for each asset i of business line j.
The cost of each operational alternative k of asset j of business line i is the
vector of resources required to implement each operation alternative.
The cost is dened as Ci;j;k;l = fCi;j;k;lgi=1;K;j=1;Ni;k=1;Mi;j;l=1;H.
The probability of failure of asset (that represents the condition where epilepsy
is not recognised or it is not treated with success) is the value from 0 to 1 which
represents the risk associated with the status quo of each asset.
The set of probabilities of failure of assets of business line i is dened as
Pi;j = fpi;jgi=1;K;j=1;Ni .
The operational alternative coecient represents the in
uence of each op-
eration alternative on the asset condition. Values of coecient are from 0 to
1.
The set of coecient is dened as Qi;j;k = fqi;j;kgi=1;K;j=1;Ni;k=1;Mi;j .
The operational alternative coecient is greater than or equal to zero and
the probability of failure of each asset after applying the operation alternative is
calculated based on initial condition of asset and on the operational alternative
coecient.
However, in the case of the operation alternatives disposition, the probability
of failure of an asset after applying the operation alternative cannot be based
on the initial condition of an asset. In that case the probability of failure is
calculated considering a negative value of the operational alternative coecient
which means the complete loss of benets.
The multicriteria decision analysis (MCDA) is the model adopted for the
calculation of the Value to the Patient (VTP) of each asset. The criteria are
built for each business line separately because each business line has its own
benets, in general, for the whole patients. In the MCDA a linear utility function
is dened:
48Futility(x)f1;x > xxmax;
x   xmin
xmax   xmin
;xmin < x < xmax;
0;x 6 xming
(1)
where, x is the value of each criteria,and xmin and xmax are the lower and
upper limits of each criteria respectively. The selection of lower and upper limits
of the criteria scale requires a separate denition for each criterion. The value
out the MCDA model for each operation alternatives of asset j of business line
i is given by:
Vi;j;k = fvi;j;kgi=1;K;j=1;Ni;k=1;Mi;j;!c
(2)
where !c = !1;::::;!Q are a set of weights that express the stakeHolders
preferences for each benet e of the business of the line.Thus, the value is the
typical weighted sum out of multicriteria decision models. The Value to The
Patien (VTP) is given by the expected value of the utility of each operation
alternative for each asset. Thus, VTP is given by :
V TPi;j;kf(1   vi;j;k)pi;j;qi;j;k  0;
(1   vi;j;k)qi;j;k < 0g
(3)
The above calculation of the VTP is based on the assumption of equivalence
of the business line at the enterprise scale. Nonetheless the problem of manage-
ment is a decision making problem ultimately. In fact, even with a quantitative
model to asses the social, economical, and environmental benets of assets it
is impossible to asses importance of a business line vs the others on the same
scale. It is case by case that stakeholders need to balance preferences and pri-
orities. The case for V TPi;j;k < 0 corresponds to the asset disposition in which
49there is the complete loss of benets. Therefore in order to consider dierent
stakeholder's preferences, VTP can be calculated as
V TP !
i;j;k = V TPi;j;k!i
(4)
Figure 6: Risk-based Multi-Criteria Decision Analysis for Epilepsy Death Risk
Reduction. The management model is universally applicable to any number of
patients and illness types.
6.2 Portofolio Decision Model
A portfolio model was developed to select candidate sets of operational alterna-
tives of which belong to multiple business lines that are "ecient" ( also called
"noninferior", "nondominated" or "Pareto optimal") in the sense that no other
single portfolio of operational alternatives could yield an improvement in one
objective without causing a degradation in at least one other objective. The
objective is the maximization of the medical quality, which implicity includes
multiple objectives that are the maximisation of the social, economical benets,
50and the minization of the probability of faliure. The number of portfolio cam-
binations is a product of the number of operation alternatives for all assets of
busines lines:
T = K
i=1
Ni
j=1Mi;j
(5)
for the set of possible cambination of operational alternatives X = fx1;:::::;xTg
The portfolio cambinationis a vector which selects operation alternatives for all
assets of all business lines, i.e. Xt = fxt;i;jgt=1;T;i=1;K;j=1;Ni.
The portfolio combination Xt constrained by the aviable resources is:
K
i=1
Ni
j=1ci;j;xt;i;j;h  rh8hRT
(6)
where h represents the resource type. The objective function for multiple busi-
ness lines according the "distance formulation" is
V TP(Xt) =
p
K
i=1V TP(Xt;i)2
In the case of Pareto optimization unconstrained to the resources for maximiza-
tion of V TP(Xt;i): if V TP(X1;i)  V TP(X2;i);8if1;Kg and jf1;Nig if if
V TP(X1;j)  V TP(X2;j) then the portfolio combination X1 dominates X2.
The Pareto optimization may also be performed conditional to two con-
straints: V TP(Xt) at the enterprise level and Cost(Xt;h) of resurce type h. Cost
is dened as Cost(Xt;h) = K
i=1
Ni
j=1ci;j;xt;i;j;h. In this case , if V TP(X1) 
V TP(X2) and Cost(X1;h) < Cost(X2;h), then the portfolio combination X1
dominates X2.
Indicatively we chose to take into account three types of patient in dierent
disease states
51Table 9: Three types of patient in dierent disease states and alternative
diagnosis considered.We have chosen to give approximately the same probability
of failure for each alternative.
Table 10: Three types of patient in dierent disease states and alternative
treatments considered.We have chosen to give approximately the same
probability of failure for each alternative.
Table 11: Model for Diagnosis. The criteria represent the benets of each
business line.We assigned an approximate weight of each criterion according to
importance.
Table 12: Model for Treatments. The criteria represent the benets of each
business line.We assigned an approximate weight of each criterion according to
importance.
52Figure 6.1: Decision trees for the diagnosis management problem. The decision is
represented by the node. The expected value to the patient (VTP) is calculated for
each "success" branch after the chance node . The coecient of criticality of each
management alternative (that multiplies the probability of failure) is proportional
to the ability of each alternative to increase the functionality of an asset.
Figure 6.2: Decision trees for the Treatments management problem. The de-
cision is represented by the node. The expected value to the patient (VTP) is
calculated for each "success" branch after the chance node . the coecient of
criticality of each management alternative (that multiplies the probability of fail-
ure) is proportional to the ability of each alternative to increase the functionality
of an asset.
53Chapter 7
Results
Graph 1,2 reports the outputs of the portfolio decision model that is schemati-
cally represented in Figure 6. The model is composed by a multicriteria decision
model out of which values of benets of each assets are determined. The benets
are weighted by the stakeholders preferences (Eq. 2). The expected Value to
The Patient is then obtained as the product of the MCDA value and the com-
plementary of the expected probability of failure (Eq. 3). It is important to
emphasize the concept of expected value and of expected probability since the
estimated quantity are not the true values that are observed in reality but just
best estimation of the assets' value and criticality. In this paper we provide a
case study with the test data, however a real estimation would be required.
Table 13: Diagnosis VTP scores set on the Pareto frontier constrained to the
55resource available (cost=20).
Table 14: Treatments VTP scores set on the Pareto frontier constrained to the
resource available (cost=20).
Table 15: Final Results VTP scores
56Graphic 1: Output of the management model. (a) Pareto frontier (green curve),
the blue and red dots represent aordable and unaordable combinations of
management alternative of assets.
Graphic 2:Outputs of the management model.Objective function proportional to
the expected value to the patient, and unconstrained to the resources available.
The green curve is the Pareto frontier unconstrained to the resources.
57Chapter 8
Conclusions
A portfolio model was developed to create an optimal budget allocation frame-
work for operation alternatives of assets of multiple business lines as a function of
assets criticality and social, economical and environmental benets. The model
is composed by a multicriteria decision model and by a Pareto optimization
component. Due to the many uncertainties in the parameters of the model, the
presented model can be used only in a indicative mode, and further develop-
ment is needed to nalize criteria and weights. Nonetheless we envision that the
formulation of criteria and weights is a more subjective calibration step to be
evaluated case by case. The inclusion of asset interdependencies, the adoption of
a probabilistic framework for criteria and weights, the representation of better
failure probabilities, the inclusion of patients stressors, and the adoption of bet-
ter utility functions are more important ingredients of the portfolio model that
will be addressed in the future. It is worth pointing out:
 The portfolio decision model allows to optimally prioritize a criteria such
as ecacy and cost, considering their benets ("triple bottom line" frame-
work), their criticality, and the future alternatives development. The Value
of The Patient is dened as an integrated measure for characterizing each
asset in an "integrated top-down" purview that. All the assets are consid-
ered together according their VTP and a Pareto ecient frontier is found
59to detect the optimal sets that maximize VTP for a given cost;
 The model can be an optimal tool for expenditures management for hospi-
tals, patients and nancial companies with the possibility of prioritizes at
some criteria than others. The Portfolio solution can be applied in dier-
ent medical environment and can be associated with a hospitals patients
database with the nal goal to eliminate the waste and optimize the sani-
tary system. The model is also 
exible to consider stakeholder preferences
variations of criteria or of business lines.
 The portfolio model potentially solves any diseases management problem
considering every asset together at the patient criticity.
 The model may be easily extended outside the boundaries of a epilepsy
diagnosis and treatments and it can constitute a tool for the prioritization
of multiple heterogenous business lines of an ecosystem.
 The portfolio model combines toghether several type of dignosi and treat-
ments, with patient state and budget available, maximizing benets and
minimizing risks in a sustainable perspective of illness.
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